These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 870162

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Liebman HA, Hum GJ, Sheehan WW, Ryden VM, Bateman JR.
    Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
    [Abstract] [Full Text] [Related]

  • 3. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Bloomfield CD, Weiss RB, Fortuny I, Vosika G, Kennedy BJ.
    Cancer; 1976 Jul; 38(1):42-8. PubMed ID: 947533
    [Abstract] [Full Text] [Related]

  • 4. Southeastern Cancer Study Group trials with nitrosoureas in Hodgkin's disease.
    Durant JR, Bartolucci A, Gams RA, Dorfman RF, Velez-Garcia E.
    Cancer Treat Rep; 1976 Jun; 60(6):781-7. PubMed ID: 782700
    [Abstract] [Full Text] [Related]

  • 5. A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
    Cooper MR, Pajak TF, Nissen NI, Stutzman L, Brunner K, Cuttner J, Falkson G, Grunwald H, Bank A, Leone L, Seligman BR, Silver RT, Weiss RB, Haurani F, Blom J, Spurr CL, Glidewell OJ, Gottlieb AJ, Holland JF.
    Cancer; 1980 Aug 15; 46(4):654-62. PubMed ID: 7397630
    [Abstract] [Full Text] [Related]

  • 6. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone.
    Gibbs GE, Peterson BA, Kennedy BJ, Vosika G, Bloomfield CD.
    Arch Intern Med; 1981 Jun 15; 141(7):897-900. PubMed ID: 7235809
    [Abstract] [Full Text] [Related]

  • 7. Combination chemotherapy of Hodgkin's disease in children.
    Kolygin BA.
    Cancer; 1976 Oct 15; 38(4):1494-7. PubMed ID: 991072
    [Abstract] [Full Text] [Related]

  • 8. Combination chemotherapy of advanced Hodgkin's disease. A review.
    Goldsmith MA, Carter SK.
    Cancer; 1974 Jan 15; 33(1):1-8. PubMed ID: 4129559
    [No Abstract] [Full Text] [Related]

  • 9. Combination chemotherapy with cyclophosphamide, vinblastine, procarbazine and prednisone in the treatment of malignant lymphomas.
    Host H, Abrahamsen AF.
    Scand J Haematol; 1973 Jan 15; 10(3):170-6. PubMed ID: 4588616
    [No Abstract] [Full Text] [Related]

  • 10. MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
    Gobbi PG, Pieresca C, Federico M, Di Renzo N, Narni F, Iannitto E, Grignani G, Cavanna L, Avanzini P, Partesotti G.
    J Clin Oncol; 1993 Apr 15; 11(4):712-9. PubMed ID: 7683044
    [Abstract] [Full Text] [Related]

  • 11. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
    Porzig KJ, Portlock CS, Robertson A, Rosenberg SA.
    Cancer; 1978 May 15; 41(5):1670-5. PubMed ID: 77180
    [Abstract] [Full Text] [Related]

  • 12. BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
    Bakemeier RF, Anderson JR, Costello W, Rosner G, Horton J, Glick JH, Hines JD, Berard CW, DeVita VT.
    Ann Intern Med; 1984 Oct 15; 101(4):447-56. PubMed ID: 6089632
    [Abstract] [Full Text] [Related]

  • 13. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG.
    Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661
    [Abstract] [Full Text] [Related]

  • 14. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA.
    J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796
    [Abstract] [Full Text] [Related]

  • 15. Randomized trial of chemotherapy versus chemotherapy plus radiotherapy for stage III-IV A & B Hodgkin's disease.
    Pavlovsky S, Santarelli MT, Muriel FS, Fernández I, Garcia I, Schwartz L, Montero C, Sanahuja FL, Magnasco H, Costa A.
    Ann Oncol; 1992 Jul 15; 3(7):533-7. PubMed ID: 1498073
    [Abstract] [Full Text] [Related]

  • 16. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease.
    Pavlovsky S, Morgenfeld M, Somoza N, Magnasco J, Sackmann Muriel F, Cavagnaro F, Suárez A, Barros CA, Saslavsky J, Garay G, Palau M, Besuschio SC.
    Medicina (B Aires); 1981 Jul 15; 41 Suppl():15-21. PubMed ID: 6896551
    [No Abstract] [Full Text] [Related]

  • 17. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Santoro A, Viviani S, Valagussa P, Bonfante V, Bonadonna G.
    Semin Oncol; 1986 Mar 15; 13(1 Suppl 1):23-6. PubMed ID: 2420012
    [Abstract] [Full Text] [Related]

  • 18. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
    Kurnick JE, White M, Ware DE, Robinson WA.
    Cancer Chemother Rep; 1975 Mar 15; 59(6):1147-50. PubMed ID: 56989
    [Abstract] [Full Text] [Related]

  • 19. CCNU, vinblastine, procarbazine and prednisone (CVPP) with extended-field radiotherapy in the treatment of early unfavorable Hodgkin's disease. A prospective study on behalf of the Gruppo Italiano per lo Studio dei Linfomi (GISL).
    Gobbi PG, Pieresca C, Cavanna L, Corbella F, Vallisa D, Federico M, Formisano R, Carotenuto M, Merli F, Callea V, Angrilli F, Silingardi V.
    Haematologica; 1996 Mar 15; 81(6):503-12. PubMed ID: 9009437
    [Abstract] [Full Text] [Related]

  • 20. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
    Case DC, Young CW, Lee BJ.
    Cancer; 1977 Apr 15; 39(4):1382-6. PubMed ID: 66972
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.